Class information for:
Level 1: IFOSFAMIDE//TROFOSFAMIDE//BNP7787

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
6272 1441 30.3 62%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
2282 4190 INTERSTITIAL CYSTITIS//CYSTITIS INTERSTITIAL//PAINFUL BLADDER SYNDROME

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 IFOSFAMIDE Author keyword 97 30% 19% 274
2 TROFOSFAMIDE Author keyword 43 79% 2% 27
3 BNP7787 Author keyword 42 94% 1% 15
4 MESNA Author keyword 27 39% 4% 56
5 GLUFOSFAMIDE Author keyword 24 82% 1% 14
6 ISOPHOSPHORAMIDE MUSTARD Author keyword 24 91% 1% 10
7 CHLOROACETALDEHYDE Author keyword 21 52% 2% 29
8 OXAZAPHOSPHORINE Author keyword 21 75% 1% 15
9 DIMESNA Author keyword 11 100% 0% 6
10 4 HYDROXYCYCLOPHOSPHAMIDE Author keyword 10 63% 1% 10

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 IFOSFAMIDE 97 30% 19% 274 Search IFOSFAMIDE Search IFOSFAMIDE
2 TROFOSFAMIDE 43 79% 2% 27 Search TROFOSFAMIDE Search TROFOSFAMIDE
3 BNP7787 42 94% 1% 15 Search BNP7787 Search BNP7787
4 MESNA 27 39% 4% 56 Search MESNA Search MESNA
5 GLUFOSFAMIDE 24 82% 1% 14 Search GLUFOSFAMIDE Search GLUFOSFAMIDE
6 ISOPHOSPHORAMIDE MUSTARD 24 91% 1% 10 Search ISOPHOSPHORAMIDE+MUSTARD Search ISOPHOSPHORAMIDE+MUSTARD
7 CHLOROACETALDEHYDE 21 52% 2% 29 Search CHLOROACETALDEHYDE Search CHLOROACETALDEHYDE
8 OXAZAPHOSPHORINE 21 75% 1% 15 Search OXAZAPHOSPHORINE Search OXAZAPHOSPHORINE
9 DIMESNA 11 100% 0% 6 Search DIMESNA Search DIMESNA
10 4 HYDROXYCYCLOPHOSPHAMIDE 10 63% 1% 10 Search 4+HYDROXYCYCLOPHOSPHAMIDE Search 4+HYDROXYCYCLOPHOSPHAMIDE

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 4 HYDROXYCYCLOPHOSPHAMIDE 72 83% 3% 40
2 N DECHLOROETHYLATION 64 79% 3% 41
3 OXAZAPHOSPHORINES 59 65% 4% 56
4 ISOPHOSPHAMIDE NSC 109724 55 87% 2% 27
5 MESNA 54 33% 9% 134
6 ISOPHOSPHORAMIDE MUSTARD 45 90% 1% 19
7 ACTIVATED CYCLOPHOSPHAMIDE 42 94% 1% 15
8 DIMESNA 41 100% 1% 15
9 IFOSFAMIDE ACTIVATION 38 70% 2% 31
10 PHOSPHORAMIDE MUSTARD 37 45% 4% 62

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Clinical pharmacokinetics of cyclophosphamide 2005 102 162 62%
Metabolism and pharmacokinetics of oxazaphosphorines 2000 99 108 69%
Nephrotoxicity-What Do We Know and What Don't We Know? 2011 16 81 53%
Oxazaphosphorines: new therapeutic strategies for an old class of drugs 2010 20 132 77%
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites 2001 58 162 85%
IFOSFAMIDE, MESNA, AND NEPHROTOXICITY IN CHILDREN 1993 166 90 72%
Cyclophosphamide and related anticancer drugs 2001 51 127 74%
The chemistry of the metabolites of cyclophosphamide 1999 83 47 77%
CLINICAL PHARMACOKINETICS OF CYCLOPHOSPHAMIDE 1991 195 53 51%
Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention 2009 14 87 68%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 KRIGO 4 75% 0.2% 3
2 NIOMECH 3 100% 0.2% 3
3 CIHR GSK CHAIR PAEDIAT CLIN PHARMACOL 3 50% 0.3% 4
4 METAB MALAD METAB U820 2 67% 0.1% 2
5 CLIN PHARMACOL TOXICOL PHARMACOKINET 1 100% 0.1% 2
6 EWING SARCOMA TRIAL 1 100% 0.1% 2
7 LESS 1 29% 0.3% 4
8 SECT DRUG TOXICOL 1 20% 0.3% 5
9 EA 3535 1 40% 0.1% 2
10 CHEM TECHNOL PHARMACEUT 1 21% 0.2% 3

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000244048 UROTOXICITY//HEMORRHAGIC CYSTITIS//PECAN NUT SHELLS
2 0.0000214406 N N N TRIETHYLENEPHOSPHORAMIDE//THIOTEPA MERCAPTURATE//TEPA
3 0.0000119253 TRABECTEDIN//ET 743//YONDELIS
4 0.0000084312 PEPTICHEMIO//ALKYLATING PEPTIDES//HUMAN MYELOMA CELLS
5 0.0000055229 NEPHROTOXICITY//SERV FARMACOL TOSSICOL//CISPLATIN NEPHROTOXICITY
6 0.0000054577 INTRATHECAL VINCRISTINE//METHYLTHIONINIUM CHLORIDE//METABOLIC ENHANCER
7 0.0000049347 2 3 4 DIARYL 5 OXO 1 2 4 TRIAZINE 6 YLIDENEACETATES//3 4 DIARYL 1 2 4 TRIAZOLO 5 CARBOXYLATES//ADEUOVIRUS
8 0.0000048171 1 3 2 DIOXAPHOSPHORINANE//DIORGANODICHLOROSILANES//ORGANOPHOSPHORUS HETEROCYCLES
9 0.0000045260 CALVERT FORMULA//CHATELUT FORMULA//SKI 2053R
10 0.0000044038 ANTINEOPLASTIC DRUGS//TOXICITY ENVIRONMENTAL//HAZARDOUS DRUGS